Regulation of Glial Cell Functions by PPAR-γ Natural and Synthetic Agonists
Author Information
Author(s): A. Bernardo Minghetti, Luisa Minghetti
Primary Institution: Istituto Superiore di Sanità, Rome, Italy
Hypothesis
PPAR-γ agonists can control neuroinflammation and neurodegeneration through their activities on glial cells.
Conclusion
PPAR-γ agonists show therapeutic potential in treating inflammatory and degenerative brain disorders.
Supporting Evidence
- PPAR-γ agonists have shown anti-inflammatory effects in experimental models of Alzheimer's and Parkinson's diseases.
- Clinical trials are ongoing with pioglitazone and rosiglitazone for treating brain disorders.
- PPAR-γ agonists can modulate the functions of glial cells, which are crucial for brain health.
Takeaway
This study looks at how certain drugs can help brain cells fight inflammation and damage, which is important for diseases like Alzheimer's and Parkinson's.
Methodology
The article reviews recent findings on the effects of PPAR-γ agonists in various experimental models and clinical studies.
Limitations
Clinical studies on PPAR-γ agonists in conditions like multiple sclerosis and amyotrophic lateral sclerosis are still lacking.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website